Blockchain Registration Transaction Record
Quantum BioPharma CEO Talks Lucid-MS and unbuzzd on Podcast
Quantum BioPharma (QNTM) executive Anthony Durkacz discusses Lucid-MS and unbuzzd in BioMedWire Podcast, revealing strategy for multiple sclerosis drug and alcohol metabolism accelerator.
This news matters because it provides investors and the public with direct insight into Quantum BioPharma's strategy for two key products: Lucid-MS for multiple sclerosis and unbuzzd for alcohol metabolism. Understanding the company's approach helps stakeholders evaluate its potential for growth and impact in the biotech sector. The executive's transparency on a podcast underscores the importance of thought leadership in demystifying complex medical innovations and building investor confidence.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x3d952dd686f4c1b290254441e395ec5734ea0d6a6a14858587787bf0e4e3617d |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | tint639m-ea6c14139729d440b5a77141aa6d7354 |